What is the clinical evidence from this study?

Study design: Observational. Population: Pulmonary hypertension. Intervention: Time period (2000 to 2013) vs. Year 2000. Primary outcome: Number of hospital admissions (p=< 0.001).

April 24, 2017Advances in respiratory medicineOpen Access

Hospital admissions for pulmonary hypertension in the United States increased from 12,066 in 2000 to 13,605 in 2013 (p<0.001), accompanied by significant increases in length of stay and costs.

Q: What are the key findings of this study?

View Full Paper

Ask AI

Bookmark

Population

Patients in the United States National Inpatient Sample Database with a primary discharge diagnosis of…

Design

Cohort

Key result

Hospital admissions for pulmonary hypertension in the United States increased from 12,066 in 2000 to 13,605 in 2013 (p<0.001), accompanied by significant increases in length of stay and costs.

Authors

RSRutuja Sikachi SSSonu Sahni DMDhruv Mehta

Discussion

Member takes

Overview

Rising PH hospitalizations and costs signal growing inpatient burden; observational trends leave open drivers and need for targeted interventions.

Study Design

Type

Observational

Multicenter

Yes

Structured PICO

Population

Patients hospitalized with a primary discharge diagnosis of pulmonary hypertension or cor pulmonale in the United States between 2000 and 2013.

Outcome

Trends in the number of hospital discharges, lengths of stays, and associated hospital costs over the study period.

Main Result

Absolute Event Rate: 13605% vs 12066%

p-value: p=< 0.001

Inpatient admissions, length of stay, and healthcare costs associated with pulmonary hypertension in the United States increased significantly between 2000 and 2013.

Cite This Study

Sikachi et al. (2017) conducted an observational in Pulmonary hypertension. Time period (2000 to 2013) vs. Year 2000 was evaluated on Number of hospital admissions (p=< 0.001). Hospital admissions for pulmonary hypertension in the United States increased from 12,066 in 2000 to 13,605 in 2013 (p<0.001), accompanied by significant increases in length of stay and costs.

synapsesocial.com/papers/6a9eb2b43bd0b4e8cb7169e3 https://doi.org/10.5603/arm.2017.0014

View Full Paper

Ask AI

Bookmark

April 24, 2017Advances in respiratory medicineOpen Access

Hospital admissions for pulmonary hypertension in the United States increased from 12,066 in 2000 to 13,605 in 2013 (p<0.001), accompanied by significant increases in length of stay and costs.

View Full Paper

Ask AI

Bookmark

Population

Patients in the United States National Inpatient Sample Database with a primary discharge diagnosis of…

Design

Cohort

Key result

Hospital admissions for pulmonary hypertension in the United States increased from 12,066 in 2000 to 13,605 in 2013 (p<0.001), accompanied by significant increases in length of stay and costs.

Authors

RSRutuja Sikachi SSSonu Sahni DMDhruv Mehta

Discussion

Member takes

Overview

Rising PH hospitalizations and costs signal growing inpatient burden; observational trends leave open drivers and need for targeted interventions.

Study Design

Type

Observational

Multicenter

Yes

Structured PICO

Population

Patients hospitalized with a primary discharge diagnosis of pulmonary hypertension or cor pulmonale in the United States between 2000 and 2013.

Outcome

Trends in the number of hospital discharges, lengths of stays, and associated hospital costs over the study period.

Main Result

Absolute Event Rate: 13605% vs 12066%

p-value: p=< 0.001

Inpatient admissions, length of stay, and healthcare costs associated with pulmonary hypertension in the United States increased significantly between 2000 and 2013.

Cite This Study

synapsesocial.com/papers/6a9eb2b43bd0b4e8cb7169e3 https://doi.org/10.5603/arm.2017.0014

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark